Change Healthcare vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 60)
Change Healthcare logo

Change Healthcare

ChallengerHealthcare

Revenue Cycle

Healthcare clearinghouse processing 15B+ annual claims acquired by Optum; 2024 ransomware attack caused $1B+ provider disruption and sparked nationwide healthcare cybersecurity overhaul.

AI VisibilityBeta
Overall Score
B60
Category Rank
#122 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
56
Perplexity
55
Gemini
62

About

Change Healthcare (now part of Optum) is a healthcare technology company providing claims processing, payment management, network intelligence, and clinical decision support tools to the US healthcare ecosystem — connecting payers, providers, pharmacies, and patients through data and technology infrastructure. Change Healthcare was acquired by UnitedHealth Group's Optum subsidiary in October 2022 following a lengthy regulatory review that included a DOJ lawsuit to block the acquisition on antitrust grounds.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

60
Overall Score
93
#122
Category Rank
#1
82
AI Consensus
80
stable
Trend
stable
56
ChatGPT
94
55
Perplexity
89
62
Gemini
94
60
Claude
92
60
Grok
98

Key Details

Category
Revenue Cycle
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Change Healthcare
Revenue Cycle

Integrations

Only Pfizer
Pfizer is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.